• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,155.62 347.14
( 0.45%)
Global Indices
Nasdaq
52,022.73 330.70
(0.64%)
Dow Jones
7,531.82 -43.47
(-0.57%)
Hang Seng
69,975.80 571.30
(0.82%)
Nikkei 225
10,504.45 73.83
(0.71%)
Forex
USD-INR
94.63 -0.29
(-0.31%)
EUR-INR
109.79 -0.04
(-0.03%)
GBP-INR
127.09 -0.16
(-0.13%)
JPY-INR
0.59 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
40.62
38458.31
EPS(TTM)
Face Value()
Div & Yield %
75.78
2
0.91
 

artemis electicals & projects ltd
EaseMyTrip plans to raise capital of Rs 500 cr
Feb 16,2026

EaseMyTrip has announced plans to raise capital up to Rs 500 crore as part of its ongoing strategy to scale key growth areas and reinforce its financial strength. The Board has approved, in principally, a proposal to raise funds through the issuance of equity shares and/or other eligible securities, subject to requisite approvals.

The proposed capital raise is intended to support EaseMyTrip's expansion across high-potential segments, particularly in hotels and holidays, while also enabling continued investments in technology, platform enhancement, and strategic opportunities aligned with its long-term business priorities. The move is aimed at providing additional flexibility to execute growth initiatives while maintaining a disciplined approach to capital allocation.